ama1-c1

Vaccineexperimental

Clinical trial activity

10 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
10
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Apr 23, 2004 (NCT00343005)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ama1-c1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01351948Phase 1Jun 1, 2011National Institute of Allergy and Infectious Diseases (NIAID), University of Oxford
NCT00984763Phase 1/Phase 2 (Phase 2)Jan 1, 2010National Institute of Allergy and Infectious Diseases (NIAID), University of Oxford
NCT00740090Phase 1Aug 11, 2008National Institute of Allergy and Infectious Diseases (NIAID)
NCT00487916Phase 1Jun 13, 2007National Institute of Allergy and Infectious Diseases (NIAID)
NCT00427167Phase 1Jan 23, 2007National Institute of Allergy and Infectious Diseases (NIAID)
NCT00414336Phase 1Dec 15, 2006National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
NCT00341250Phase 1/Phase 2 (Phase 2)Jan 19, 2006National Institute of Allergy and Infectious Diseases (NIAID)
NCT00344539Phase 1May 1, 2005National Institute of Allergy and Infectious Diseases (NIAID)
NCT00340574Phase 1Mar 8, 2005National Institute of Allergy and Infectious Diseases (NIAID)
NCT00343005Phase 1Apr 23, 2004National Institute of Allergy and Infectious Diseases (NIAID)
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institute of Allergy and Infectious Diseases (NIAID)Government10822004
University of OxfordAcademic/Hospital2222010
National Institutes of Health (NIH)Government1012006
3 organizations
Page 1 / 1